Delhi Chief Minister Arvind Kejriwal on Saturday urged PM Modi to stop flights from South Africa, Botswana and Hong Kong where new Covid-19 variants have been detected
With effect from Sunday, arrivals from South Africa, Botswana, Zimbabwe, Namibia, Lesotho and Eswatini are required to undergo mandatory quarantine
World Health Organization is holding a special session to flesh out information about a worrying new variant of the coronavirus that has emerged in South Africa
Relaxed prevention measures and low vaccination rates in some areas explain the latest surge, says WHO Europe chief
In a tweet, the WHO said it has granted emergency use listing (EUL) to Covaxin
On Wednesday, WHO issued an emergency use listing (EUL) for Covaxin
Tedros, an Ethiopian national who is the first African to head WHO, has overseen the agency's complex response to the Covid-19 pandemic
The coronavirus pandemic will come to an end when all the countries start using the available health tools effectively, the WHO chief said
As a decision is awaited on the Emergency Use Listing of Covaxin being manufactured in India, a top WHO official has said the process of thoroughly evaluating a vaccine for use and recommending it sometimes takes longer time but it has to be ensured that the right advice is given to the world "even if it takes another week or two". The World Health Organisation is very clear that we want all countries to recognise vaccines that have been given an Emergency Use Listing (EUL) by the WHO advisory process. But it's also very important that WHO, when it makes a recommendation like that, is making that globally, WHO Health Emergencies Programme Executive Director Dr Mike Ryan said. Ryan was responding to a question during a recent virtual Q&A on whether there will be a definitive answer on Covaxin EUL by October 26. WHO Chief Scientist Soumya Swaminathan had said in a tweet earlier that the technical advisory group at WHO will meet on October 26 to consider the Emergency Use Listing for
Live news updates: Insolvency court allows creditors and shareholders of Reliance Retail Ventures to hold meetings.
But the slow pace of visa approval remains a challenge
A advisory panel of the World Health Organization is set to discuss the need for Covid-19 booster doses on November 11
: Bharat Biotech on Friday said it has submitted all the data pertaining to its COVID-19 vaccine Covaxin to the World health organisation for Emergency Use Listing (EUL) and is awaiting feedback from the global health watchdog. The WHO is currently reviewing the data submitted by the vaccine maker and the date for a decision on the jab is yet "to be confirmed," according to the update available on WHO website. "#COVAXIN clinical trial data was fully compiled & available in June 2021. All Data submitted for Emergency Use Listing (EUL) Application to World Health Organization in early July. We have responded to any clarifications sought by #WHO and are awaiting further feedback," Bharat Biotech tweeted. As a responsible manufacturer with past approvals for its other vaccines, the company said it would not find it appropriate to speculate or comment on approval process and its timelines, it further said. "We are continuing to work diligently on obtaining WHO EUL at the earliest, the .
Coronavirus live updates: Kerala logs over 20,000 cases; no fresh death in Delhi. Catch all the live updates here
The national recovery rate was recorded at 97.49 per cent, the health ministry said.
The Nifty IT index put up a strong show with a 0.7 per cent gain while the Nifty Realty index slipped 0.8 per cent.
Taiwan's efforts to join WHO begin in 1997
India has so far administered 489,342,295 vaccine doses. That is 1538.22 per cent of its total caseload, and 35.05 per cent of its population
The WHO on Wednesday called for a "moratorium" on booster shots of the Covid-19 vaccine until at least the end of September
Coronavirus live updates: Serum Institute to test US firm's vaccines on children; Brazil cities ease curbs.